칸나비디올(CBD) 오일 시장 규모, 점유율 및 동향 분석 보고서 : 원료별, 제품별, 용도별, 제제별, 유통 채널별, 지역별 및 부문별 예측(2026-2033년)

Cannabidiol Oil Market Summary

The global cannabidiol oil market size was estimated at USD 4.4 billion in 2025 and is projected to reach USD 8.3 billion by 2033, growing at a CAGR of 7.9% from 2026 to 2033. The market is growing owing to the increasing legalization and acceptance of hemp-derived CBD products, growing consumers' preference for natural and plant-based wellness solutions, and strong research on the medical benefits of CBD in therapeutic applications.

In addition, the greater availability of CBD online and its expansion into supplements, cosmetics, beverages, and healthcare products, in combination with improved manufacturing and labeling standards, are also building consumer trust and driving market growth.

The section below outlines the key factors driving market growth, highlighting supportive CBD regulations that are enhancing consumer confidence, ongoing product innovation, and the development of high-potency CBD formulations, rising pet humanization and awareness of CBD benefits in pet wellness, and the increasing legalization and use of medical cannabis across different countries.

Global Cannabidiol Oil Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global cannabidiol (CBD) oil market report based on source, products, application, formulation, distribution channel, and region:

• Source Outlook (Revenue, USD Billion, 2021 - 2033)
• Hemp-derived CBD Oil
• Marijuana-derived CBD Oil
• Products Outlook (Revenue, USD Billion, 2021 - 2033)
• Tinctures (dropper bottles)
• Oral CBD Oil (ingestible)
• Topical CBD Oil (oil-based only)
• Application Outlook (Revenue, USD Billion, 2021 - 2033)
• Medical/therapeutic Use
• Wellness & Lifestyle
• Personal Care & Cosmetics
• Pet Care
• Others
• Formulation Outlook (Revenue, USD Billion, 2021 - 2033)
• Full-Spectrum CBD
• Broad-Spectrum CBD
• CBD Isolate
• Distribution Channel Outlook (Revenue, USD Billion, 2021 - 2033)
• B2C / Indirect Sales
• B2B / Direct Sales
• Institutional/medical Channel
• Regional Outlook (Revenue, USD Billion, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Netherlands
  • Switzerland
  • Spain
  • Poland
  • Czech Republic
  • Croatia
• Asia
  • China
  • Japan
  • India
  • Thailand
• Oceania
  • Australia
  • New Zealand
• Latin America & Caribbean
  • Brazil
  • Uruguay
  • Colombia
  • Argentina
• Africa

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Segment Scope
  • 1.1.2. Regional Scope
  • 1.1.3. Estimates And Forecast Timeline
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased Database
  • 1.3.2. GVR's Internal Database
  • 1.3.3. Secondary Sources
  • 1.3.4. Primary Research
  • 1.3.5. Details of Primary Research
• 1.4. Information or Data Analysis
  • 1.4.1. Data Analysis Models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
  • 1.6.1. Commodity Flow Analysis (Model 1)
    • 1.6.1.1. Approach 1: Commodity Flow Approach
• 1.7. Research Assumptions
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Source Outlook
  • 2.2.2. Products Outlook
  • 2.2.3. Application Outlook
  • 2.2.4. Formulation Outlook
  • 2.2.5. Distribution Channel Outlook
  • 2.2.6. Regional Outlook
• 2.3. Competitive Insights

Chapter 3. Cannabidiol Oil Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Ancillary Market Outlook
• 3.2. Cannabis Regulatory Scenario, By Country
  • 3.2.1. U.S.
    • 3.2.1.1. Cultivation/Production
    • 3.2.1.2. Legal Status (CBD & THC)
    • 3.2.1.3. Regulatory Bodies Involved
  • 3.2.2. Canada
    • 3.2.2.1. Cultivation/Production
    • 3.2.2.2. Legal Status (CBD & THC)
    • 3.2.2.3. Regulatory Bodies Involved
  • 3.2.3. Mexico
    • 3.2.3.1. Cultivation/Production
    • 3.2.3.2. Legal Status (CBD & THC)
    • 3.2.3.3. Regulatory Bodies Involved
  • 3.2.4. Germany
    • 3.2.4.1. Cultivation/Production
    • 3.2.4.2. Legal Status (CBD & THC)
    • 3.2.4.3. Regulatory Bodies Involved
  • 3.2.5. UK
    • 3.2.5.1. Cultivation/Production
    • 3.2.5.2. Legal Status (CBD & THC)
    • 3.2.5.3. Regulatory Bodies Involved
  • 3.2.6. Italy
    • 3.2.6.1. Cultivation/Production
    • 3.2.6.2. Legal Status (CBD & THC)
    • 3.2.6.3. Regulatory Bodies Involved
  • 3.2.7. France
    • 3.2.7.1. Cultivation/Production
    • 3.2.7.2. Legal Status (CBD & THC)
    • 3.2.7.3. Regulatory Bodies Involved
  • 3.2.8. Netherlands
    • 3.2.8.1. Cultivation/Production
    • 3.2.8.2. Legal Status (CBD & THC)
    • 3.2.8.3. Regulatory Bodies Involved
  • 3.2.9. Switzerland
    • 3.2.9.1. Cultivation/Production
    • 3.2.9.2. Legal Status (CBD & THC)
    • 3.2.9.3. Regulatory Bodies Involved
  • 3.2.10. Spain
    • 3.2.10.1. Cultivation/Production
    • 3.2.10.2. Legal Status (CBD & THC)
    • 3.2.10.3. Regulatory Bodies Involved
  • 3.2.11. Poland
    • 3.2.11.1. Cultivation/Production
    • 3.2.11.2. Legal Status (CBD & THC)
    • 3.2.11.3. Regulatory Bodies Involved
  • 3.2.12. Czech Republic
    • 3.2.12.1. Cultivation/Production
    • 3.2.12.2. Legal Status (CBD & THC)
    • 3.2.12.3. Regulatory Bodies Involved
  • 3.2.13. Croatia
    • 3.2.13.1. Cultivation/Production
    • 3.2.13.2. Legal Status (CBD & THC)
    • 3.2.13.3. Regulatory Bodies Involved
  • 3.2.14. China
    • 3.2.14.1. Cultivation/Production
    • 3.2.14.2. Legal Status (CBD & THC)
    • 3.2.14.3. Regulatory Bodies Involved
  • 3.2.15. India
    • 3.2.15.1. Cultivation/Production
    • 3.2.15.2. Legal Status (CBD & THC)
    • 3.2.15.3. Regulatory Bodies Involved
  • 3.2.16. Japan
    • 3.2.16.1. Cultivation/Production
    • 3.2.16.2. Legal Status (CBD & THC)
    • 3.2.16.3. Regulatory Bodies Involved
  • 3.2.17. Thailand
    • 3.2.17.1. Cultivation/Production
    • 3.2.17.2. Legal Status (CBD & THC)
    • 3.2.17.3. Regulatory Bodies Involved
  • 3.2.18. Australia
    • 3.2.18.1. Cultivation/Production
    • 3.2.18.2. Legal Status (CBD & THC)
    • 3.2.18.3. Regulatory Bodies Involved
  • 3.2.19. New Zealand
    • 3.2.19.1. Cultivation/Production
    • 3.2.19.2. Legal Status (CBD & THC)
    • 3.2.19.3. Regulatory Bodies Involved
  • 3.2.20. Brazil
    • 3.2.20.1. Cultivation/Production
    • 3.2.20.2. Legal Status (CBD & THC)
    • 3.2.20.3. Regulatory Bodies Involved
  • 3.2.21. Uruguay
    • 3.2.21.1. Cultivation/Production
    • 3.2.21.2. Legal Status (CBD & THC)
    • 3.2.21.3. Regulatory Bodies Involved
  • 3.2.22. Colombia
    • 3.2.22.1. Cultivation/Production
    • 3.2.22.2. Legal Status (CBD & THC)
    • 3.2.22.3. Regulatory Bodies Involved
  • 3.2.23. Africa
    • 3.2.23.1. Cultivation/Production
    • 3.2.23.2. Legal Status (CBD & THC)
    • 3.2.23.3. Regulatory Bodies Involved
• 3.3. Market Dynamics
  • 3.3.1. Market Driver Analysis
  • 3.3.2. Market Restraint Analysis
• 3.4. Cannabidiol (CBD) Oil: Market Analysis Tools
  • 3.4.1. Industry Analysis - Porter's
  • 3.4.2. PESTLE Analysis
• 3.5. Market Trends:
• 3.6. Regulatory Scenario by Country
• 3.7. Jurisdiction Analysis by Country
• 3.8. Cannabis Ecophysiology Analysis
  • 3.8.1. Key Environmental Parameters and their Impact Analysis
  • 3.8.2. Commercial Implications
  • 3.8.3. Technological Integration
  • 3.8.4. Market Relevance
• 3.9. Cannabis Consumption Pattern Analysis, by region
• 3.10. Legal Cannabis Potential Trade Opportunity, by region
  • 3.10.1. Global Legal Marijuana Trade Route
  • 3.10.2. Global Hemp Trade Route
• 3.11. List of Countries Importing Hemp
  • 3.11.1. Top Five Countries That Import Yarn of hemp (cannabis sativa L.) and Their Trade Values
• 3.12. List of Countries Exporting Hemp
  • 3.12.1. Top Five Countries That Export Yarn of hemp (cannabis sativa L.) and Their Trade Values
• 3.13. List of Countries Importing and Exporting Medical Cannabis
  • 3.13.1. List of Countries Importing Cannabis Oils
  • 3.13.2. List of Countries Exporting Cannabis Oils
  • 3.13.3. List of Countries Importing Hemp Seed
  • 3.13.4. List of Countries Exporting Hemp Seed
  • 3.13.5. List of Countries Importing Cannabis Flowers
  • 3.13.6. List of Countries Exporting Cannabis Flowers
• 3.14. Legal Cannabis Seed to Shelf Story
  • 3.14.1. Section Description
  • 3.14.2. Cultivators & Growers
  • 3.14.3. Manufacturers & Producers
  • 3.14.4. Testers
  • 3.14.5. Wholesalers & Distributors
  • 3.14.6. Retailers
  • 3.14.7. Supply Chain Analysis
  • 3.14.8. Supply Chain Network from Hemp Cultivators to CBD Consumer Products
  • 3.14.9. Supply Chain Network of Hemp Biomass to Industrial Applications
  • 3.14.10. Supply Chain Network from Marijuana Plants to Marijuana Oil

Chapter 4. Cannabidiol Oil Market Segment Analysis, By Source, 2021 - 2033 (USD Million)

• 4.1. Definition And Scope
• 4.2. Source Market Share Analysis, 2025 & 2033
• 4.3. Segment Dashboard
• 4.4. Global Cannabidiol (CBD) Oil Market, By Source, 2021 - 2033
• 4.5. Hemp-derived CBD Oil
  • 4.5.1. Hemp-derived Cannabidiol (CBD) Oil Market Estimates And Forecast, 2021 - 2033 (USD Million)
• 4.6. Marijuana-derived CBD Oil
  • 4.6.1. Marijuana-derived Cannabidiol (CBD) Oil Market Estimates And Forecast, 2021 - 2033 (USD Million)

Chapter 5. Cannabidiol Oil Market Segment Analysis, By Products, 2021 - 2033 (USD Million)

• 5.1. Definition And Scope
• 5.2. Products Market Share Analysis, 2025 & 2033
• 5.3. Segment Dashboard
• 5.4. Global Cannabidiol (CBD) Oil Market, By Products, 2021 - 2033
• 5.5. Tinctures (dropper bottles)
  • 5.5.1. Tinctures (dropper bottles) Market Estimates And Forecast, 2021 - 2033 (USD Million)
• 5.6. Oral CBD oil (ingestible)
  • 5.6.1. Oral CBD oil (ingestible) Market Estimates And Forecast, 2021 - 2033 (USD Million)
• 5.7. Topical CBD oil (oil-based only)
  • 5.7.1. Topical CBD oil (oil-based only) Market Estimates And Forecast, 2021 - 2033 (USD Million)

Chapter 6. Cannabidiol Oil Market Segment Analysis, By Application, 2021 - 2033 (USD Million)

• 6.1. Definition And Scope
• 6.2. Application Market Share Analysis, 2025 & 2033
• 6.3. Segment Dashboard
• 6.4. Global Cannabidiol (CBD) Oil Market, By Application, 2021 - 2033
• 6.5. Medical/therapeutic Use
  • 6.5.1. Medical/therapeutic Use Market Estimates And Forecast, 2021 - 2033 (USD Million)
• 6.6. Wellness & Lifestyle
  • 6.6.1. Wellness & Lifestyle Market Estimates And Forecast, 2021 - 2033 (USD Million)
• 6.7. Personal Care & Cosmetics
  • 6.7.1. Personal Care & Cosmetics Market Estimates And Forecast, 2021 - 2033 (USD Million)
• 6.8. Pet Care
  • 6.8.1. Pet Care Market Estimates And Forecast, 2021 - 2033 (USD Million)
• 6.9. Others
  • 6.9.1. Others Market Estimates And Forecast, 2021 - 2033 (USD Million)

Chapter 7. Cannabidiol Oil Market Segment Analysis, By Formulation, 2021 - 2033 (USD Million)

• 7.1. Definition And Scope
• 7.2. Formulation Market Share Analysis, 2025 & 2033
• 7.3. Segment Dashboard
• 7.4. Global Cannabidiol (CBD) Oil Market, By Formulation, 2021 - 2033
• 7.5. Full-Spectrum CBD
  • 7.5.1. Full-Spectrum CBD Market Estimates And Forecast, 2021 - 2033 (USD Million)
• 7.6. Broad-Spectrum CBD
  • 7.6.1. Broad-Spectrum CBD Market Estimates And Forecast, 2021 - 2033 (USD Million)
• 7.7. CBD Isolate
  • 7.7.1. CBD Isolate Market Estimates And Forecast, 2021 - 2033 (USD Million)

Chapter 8. Cannabidiol Oil Market Segment Analysis, By Distribution Channel, 2021 - 2033 (USD Million)

• 8.1. Definition And Scope
• 8.2. Distribution Channel Market Share Analysis, 2025 & 2033
• 8.3. Segment Dashboard
• 8.4. Global Cannabidiol (CBD) Oil Market, By Distribution Channel, 2021 - 2033
• 8.5. B2C / Indirect Sales
  • 8.5.1. B2C / Indirect Sales Market Estimates And Forecast, 2021 - 2033 (USD Million)
• 8.6. B2B / Direct Sales
  • 8.6.1. B2B / Direct Sales Market Estimates And Forecast, 2021 - 2033 (USD Million)
• 8.7. Institutional/medical Channel
  • 8.7.1. Institutional/medical Channel Market Estimates And Forecast, 2021 - 2033 (USD Million)

Chapter 9. Cannabidiol Oil Market Segment Analysis, By Region, 2021 - 2033 (USD Million)

• 9.1. Regional Market Share Analysis, 2025 & 2030
• 9.2. Regional Market Dashboard
• 9.3. Regional Market Snapshot
• 9.4. Cannabidiol (CBD) Oil Market Share By Region, 2025 & 2030
• 9.5. North America
  • 9.5.1. North America Cannabidiol (CBD) Oil Market, 2021 - 2033 (USD Million)
  • 9.5.2. U.S.
    • 9.5.2.1. U.S. Cannabidiol (CBD) Oil Market, 2021 - 2033 (USD Million)
  • 9.5.3. Canada
    • 9.5.3.1. Canada Cannabidiol (CBD) Oil Market, 2021 - 2033 (USD Million)
  • 9.5.4. Mexico
    • 9.5.4.1. Mexico Cannabidiol (CBD) Oil Market, 2021 - 2033 (USD Million)
• 9.6. Europe
  • 9.6.1. Europe Cannabidiol (CBD) Oil Market, 2021 - 2033 (USD Million)
  • 9.6.2. UK
    • 9.6.2.1. UK Cannabidiol (CBD) Oil Market, 2021 - 2033 (USD Million)
  • 9.6.3. Germany
    • 9.6.3.1. Germany Cannabidiol (CBD) Oil Market, 2021 - 2033 (USD Million)
  • 9.6.4. France
    • 9.6.4.1. France Cannabidiol (CBD) Oil Market, 2021 - 2033 (USD Million)
  • 9.6.5. Italy
    • 9.6.5.1. Italy Cannabidiol (CBD) Oil Market, 2021 - 2033 (USD Million)
  • 9.6.6. Spain
    • 9.6.6.1. Spain Cannabidiol (CBD) Oil Market, 2021 - 2033 (USD Million)
  • 9.6.7. Netherlands
    • 9.6.7.1. Netherlands Cannabidiol (CBD) Oil Market, 2021 - 2033 (USD Million)
  • 9.6.8. Switzerland
    • 9.6.8.1. Switzerland Cannabidiol (CBD) Oil Market, 2021 - 2033 (USD Million)
  • 9.6.9. Poland
    • 9.6.9.1. Poland Cannabidiol (CBD) Oil Market, 2021 - 2033 (USD Million)
  • 9.6.10. Czech Republic
    • 9.6.10.1. Czech Republic Cannabidiol (CBD) Oil Market, 2021 - 2033 (USD Million)
  • 9.6.11. Croatia
    • 9.6.11.1. Croatia Cannabidiol (CBD) Oil Market, 2021 - 2033 (USD Million)
• 9.7. Asia
  • 9.7.1. Japan
    • 9.7.1.1. Japan Cannabidiol (CBD) Oil Market, 2021 - 2033 (USD Million)
  • 9.7.2. China
    • 9.7.2.1. China Cannabidiol (CBD) Oil Market, 2021 - 2033 (USD Million)
  • 9.7.3. India
    • 9.7.3.1. India Cannabidiol (CBD) Oil Market, 2021 - 2033 (USD Million)
  • 9.7.4. Thailand
    • 9.7.4.1. Thailand Cannabidiol (CBD) Oil Market, 2021 - 2033 (USD Million)
• 9.8. Oceania
  • 9.8.1. Australia
    • 9.8.1.1. Australia Cannabidiol (CBD) Oil Market, 2021 - 2033 (USD Million)
  • 9.8.2. New Zealand
    • 9.8.2.1. New Zealand Cannabidiol (CBD) Oil Market, 2021 - 2033 (USD Million)
• 9.9. Latin America & Caribbean
  • 9.9.1. Brazil
    • 9.9.1.1. Brazil Cannabidiol (CBD) Oil Market, 2021 - 2033 (USD Million)
  • 9.9.2. Uruguay
    • 9.9.2.1. Uruguay Cannabidiol (CBD) Oil Market, 2021 - 2033 (USD Million)
  • 9.9.3. Colombia
    • 9.9.3.1. Colombia Cannabidiol (CBD) Oil Market, 2021 - 2033 (USD Million)
  • 9.9.4. Argentina
    • 9.9.4.1. Argentina Cannabidiol (CBD) Oil Market, 2021 - 2033 (USD Million)
• 9.10. Africa
  • 9.10.1. Africa Cannabidiol (CBD) Oil Market, 2021 - 2033 (USD Million)

Chapter 10. Competitive Landscape

• 10.1. Recent Developments & Impact Analysis, By Key Market Participants
• 10.2. Company Categorization
• 10.3. Company Profiles
  • 10.3.1. Charlotte's Web CBD & Botanicals
    • 10.3.1.1. Company Overview
    • 10.3.1.2. Financial Performance
    • 10.3.1.3. Product Benchmarking
    • 10.3.1.4. Strategic Initiatives
  • 10.3.2. Canopy Growth Corporation
    • 10.3.2.1. Company Overview
    • 10.3.2.2. Financial Performance
    • 10.3.2.3. Product Benchmarking
    • 10.3.2.4. Strategic Initiatives
  • 10.3.3. Aurora Cannabis Inc.
    • 10.3.3.1. Company Overview
    • 10.3.3.2. Financial Performance
    • 10.3.3.3. Product Benchmarking
    • 10.3.3.4. Strategic Initiatives
  • 10.3.4. Tilray Brands, Inc.
    • 10.3.4.1. Company Overview
    • 10.3.4.2. Financial Performance
    • 10.3.4.3. Product Benchmarking
    • 10.3.4.4. Strategic Initiatives
  • 10.3.5. Jazz Pharmaceuticals plc
    • 10.3.5.1. Company Overview
    • 10.3.5.2. Financial Performance
    • 10.3.5.3. Product Benchmarking
    • 10.3.5.4. Strategic Initiatives
  • 10.3.6. CV Sciences (PlusCBD Oil)
    • 10.3.6.1. Company Overview
    • 10.3.6.2. Financial Performance
    • 10.3.6.3. Product Benchmarking
    • 10.3.6.4. Strategic Initiatives
  • 10.3.7. Medterra CBD
    • 10.3.7.1. Company Overview
    • 10.3.7.2. Financial Performance
    • 10.3.7.3. Product Benchmarking
    • 10.3.7.4. Strategic Initiatives
  • 10.3.8. CBDistillery
    • 10.3.8.1. Company Overview
    • 10.3.8.2. Financial Performance
    • 10.3.8.3. Product Benchmarking
    • 10.3.8.4. Strategic Initiatives
  • 10.3.9. Elixinol
    • 10.3.9.1. Company Overview
    • 10.3.9.2. Financial Performance
    • 10.3.9.3. Product Benchmarking
    • 10.3.9.4. Strategic Initiatives
  • 10.3.10. NuLeaf Naturals
    • 10.3.10.1. Company Overview
    • 10.3.10.2. Financial Performance
    • 10.3.10.3. Product Benchmarking
    • 10.3.10.4. Strategic Initiatives